![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
Title
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
Phase ![sort descending](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/arrow_down.gif)
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
Protocol IDs
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
WHC-MRI-GU-2006-097
NCT00397761
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
2006-0827
NCT00481884
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
CHNMC-05042
NCT00182793
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
0903-882
0309006307, NCT00195091
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
CHNMC-05015
NCT00295893
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Oxidized Glutathione (NOV-002), Doxorubicin, Cyclophosphamide, and Docetaxel in Treating Women With Newly Diagnosed Stage IIB, or Stage IIIC Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
MUSC-101072
MUSC-HR-17111, 101072, NCT00499122
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Sunitinib and Combination Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
UWCC-6488
6488, UWCC-UW-6488, UWCC-07-6437-H/A, NCT00513695
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
F061229006
UAB 0648, NCT00530868
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
LJCC 07-03
NCT00542191
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Phase II Neoadjuvant in Inflammatory Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
2007-0818
NCT00756470
![](https://webarchive.library.unt.edu/eot2008/20081102090608im_/http://www.cancer.gov/images/spacer.gif)
|
|